SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-261050
Filing Date
2022-10-12
Accepted
2022-10-12 08:47:03
Documents
16
Period of Report
2022-10-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d283495d8k.htm   iXBRL 8-K 53319
2 EX-99.1 d283495dex991.htm EX-99.1 16862
3 EX-99.2 d283495dex992.htm EX-99.2 11606
7 GRAPHIC g283495ds1.jpg GRAPHIC 5378
8 GRAPHIC g283495dsp15.jpg GRAPHIC 3688
  Complete submission text file 0001193125-22-261050.txt   227870

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20221011.xsd EX-101.SCH 2873
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20221011_lab.xml EX-101.LAB 17237
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20221011_pre.xml EX-101.PRE 10824
10 EXTRACTED XBRL INSTANCE DOCUMENT d283495d8k_htm.xml XML 3225
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 221305639
SIC: 3841 Surgical & Medical Instruments & Apparatus